Outcomes for immuno-chemotherapy based treatment in patients with poorly differentiated extrapulmonary neuroendocrine carcinoma

被引：0
|
作者：
Kumar, Sakthi
Talabi, Toluwalase
Mahmoudieh, Mahta
Pennington, Daniel
Saboda, Kathylynn
Arshad, Junaid
Scott, Aaron James
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] Univ Arizona, Coll Med Tucson, Tucson, AZ USA
[3] Univ Arizona, Dept Neurosci, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14619
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Carboplatin and etoposide chemotherapy in extrapulmonary poorly differentiated neuroendocrine carcinomas
    Galdy, S.
    Aurilio, G.
    Radice, D.
    Spada, F.
    Cella, C. A.
    Frezza, A. M.
    Nole, F.
    Fazio, N.
    ANNALS OF ONCOLOGY, 2015, 26 : 138 - 138
  • [2] Efficacy of FOLFIRI as a second -line in extrapulmonary poorly differentiated neuroendocrine carcinoma
    Fabregat-Franco, Carles
    Munoz, M. Nieva
    Martin, F. Perez
    Ruffinelli, J.
    Vivas, C. Santos
    Sanchez, C.
    Salazar, R.
    Teule, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
    Apostolidis, Leonidas
    Bergmann, Frank
    Jaeger, Dirk
    Winkler, Eva Caroline
    CANCER MEDICINE, 2016, 5 (09): : 2261 - 2267
  • [4] Safety of Irinotecan-based chemotherapy as second-line treatment in extrapulmonary poorly differentiated neuroendocrine carcinomas (NECs)
    Bardasi, C.
    Spallanzani, A.
    Luppi, G.
    Bertolini, F.
    Fontana, A.
    Salati, M.
    Caputo, F.
    Santini, C.
    Cerma, K.
    Dominici, M.
    Gelsomino, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 156 - 156
  • [5] Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma
    Ikeda, Masafumi
    Okuyama, Hiroyuki
    Takahashi, Hideaki
    Ohno, Izumi
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Kondo, Shunsuke
    Morizane, Chigusa
    Ueno, Hideki
    Okusaka, Takuji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (08) : 623 - 627
  • [6] Efficacy of 2nd-line Chemotherapy in Patients With Poorly Differentiated, High Grade Extrapulmonary Neuroendocrine Carcinoma (PD NEC)
    McGarrah, Patrick
    Leventakos, Konstantinos
    Westin, Gustavo
    Finnes, Heidi
    Molina, Julian
    Hobday, Timothy
    Halfdanarson, Thorvardur
    PANCREAS, 2019, 48 (03) : 446 - 446
  • [7] Efficacy of 2nd-line chemotherapy in patients with poorly differentiated, high grade extrapulmonary neuroendocrine carcinoma (PD NEC).
    McGarrah, Patrick Walsh
    Leventakos, Konstantinos
    Hobday, Timothy J.
    Molina, Julian R.
    Finnes, Heidi Diann
    Halfdanarson, Thorvardur Ragnar
    Westin, Gustavo Figueiredo Marcondes
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Treatment of Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas
    Gupta, Anumeha
    Duque, Marvin
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2013, 14 (04): : 381 - 383
  • [9] Surgery after Neoadjuvant Chemotherapy for Locally Advanced Extrapulmonary Poorly Differentiated Neuroendocrine Cancer
    Lessing, Yonatan
    Ben-Haim, Menahem
    Lahat, Guy
    Nackache, Richard
    Klausner, Joseph M.
    Shmueli, Einat
    Lubezky, Nir
    AMERICAN SURGEON, 2011, 77 (08) : 1102 - 1104
  • [10] Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Nitya Raj
    Jennifer A. Chan
    Stephanie J. Wang
    Rahul R. Aggarwal
    Susan Calabrese
    April DeMore
    Lawrence Fong
    Jennifer Grabowsky
    Thomas A. Hope
    Kanti Pallav Kolli
    Claire K. Mulvey
    Pamela N. Munster
    Kimberly Perez
    Sippy Punn
    Diane Reidy-Lagunes
    Sofia Von Fedak
    Li Zhang
    Emily K. Bergsland
    British Journal of Cancer, 2023, 129 : 291 - 300
12345